후천적 신경근육이음부질환 환자에 대한 접근방법
Approach to Patients with Acquired Neuromuscular Junction Diseases
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
KoreaNeuromuscular junction (NMJ) diseases include myasthenia gravis, Lambert-Eaton myasthenic syndrome, botulism and congenital myasthenic syndromes. NMJ diseases have a wide range of clinical presentations. A common feature of these conditions is muscle weakness that predominates in certain muscle groups and fluctuates in response to effort and rest. The diagnosis of NMJ diseases is established by neurologic manifestations, serologic tests and neurophysiologic tests. The clinical presentation determines which diagnostic tests should be used in patients with these diseases. This review summarizes the approach to patients with acquired NMJ diseases.
Abstract
KoreaNeuromuscular junction (NMJ) diseases include myasthenia gravis, Lambert-Eaton myasthenic syndrome, botulism and congenital myasthenic syndromes. NMJ diseases have a wide range of clinical presentations. A common feature of these conditions is muscle weakness that predominates in certain muscle groups and fluctuates in response to effort and rest. The diagnosis of NMJ diseases is established by neurologic manifestations, serologic tests and neurophysiologic tests. The clinical presentation determines which diagnostic tests should be used in patients with these diseases. This review summarizes the approach to patients with acquired NMJ diseases.
참고문헌 (24)
- Meriggioli MN, "Advances in the diagnosis of neuromuscular junction disorders", Am J Phys Med Rehabil, 84, pp.627~638 (2005)
- Ha JC, "Myasthenia gravis and related disorders:pathology and molecular pathogenesis", Biochim Biophys Acta, 1852, pp.651~657 (2015)
- Liang CL, "Neuromuscular Junction Disorders", Pm R, 5, pp.S81~S88 (2013)
- Verschuuren JJ, "Clinical aspects of myasthenia explained", Autoimmunity, 43, pp.344~352 (2010)
- Smith SV, "Update on Ocular Myasthenia Gravis", Neurol Clin, 35, pp.115~123 (2017)
- Hehir MK, "Generalized Myasthenia Gravis:Classification, Clinical Presentation, Natural History, and Epidemiology", Neurol Clin, 36, pp.253~260 (2018)
- Jaretzki A 3rd, "Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America", Neurology, 55, pp.16~23 (2000)
- Evoli A, "Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase", Autoimmun Rev, 12, pp.931~935 (2013)
- Morren J, "Myasthenia gravis with muscle-specific tyrosine kinase antibodies: a narrative review", Muscle Nerve, 58, pp.344~358 (2018)
- Conti-Fine BM, "Myasthenia gravis:past, present, and future", J Clin Invest, 116, pp.2843~2854 (2006)
- Meriggioli MN, "Muscle autoantibodies in myasthenia gravis: beyond diagnosis?", Expert Rev Clin Immunol, 8, pp.427~438 (2012)
- Evoli A, "Myasthenia gravis: new developments in research and treatment", Curr Opin Neurol, 30, pp.464~470 (2017)
- Gilhus NE, "Myasthenia gravis: subgroup classification and therapeutic strategies", Lancet Neurol, 14, pp.1023~1036 (2015)
- Howard JF Jr, "Electrodiagnosis of Disorders of Neuromuscular Transmission", Phys Med Rehabil Clin N Am, 24, pp.169~192 (2013)
- Priola AM, "Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor", Clin Radiol, 69, pp.e230~e245 (2014)
- Kesner VG, "Lambert-Eaton Myasthenic Syndrome", Neurol Clin, 36, pp.379~394 (2018)
- Titulaer MJ, "Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies", Lancet Neurol, 10, pp.1098~1107 (2011)
- Gable KL, "Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism", Semin Neurol, 35, pp.340~346 (2015)
- Bekircan-Kurt CE, "Voltage gated calcium channel antibody-related neurological diseases", World J Clin Cases, 3, pp.293~300 (2015)
- Oh SJ, "Distinguishing Features of the Repetitive Nerve Stimulation Test Between Lambert-Eaton Myasthenic Syndrome and Myasthenia Gravis, 50-Year Reappraisal", J Clin Neuromuscul Dis, 19, pp.66~75 (2017)
- Lindström M, "Laboratory diagnostics of botulism", Clin Microbiol Rev, 19, pp.298~314 (2006)
- Carrillo-Marquez MA, "Botulism", Pediatr Rev, 37, pp.183~192 (2016)
- 유창범, "식중독", 대한의사협회지, 54(6), pp.617~626 (2011), 대한의사협회
- Berrih-Aknin S, "Diagnostic and clinical classification of autoimmune myasthenia gravis", J Autoimmun, 48-49, pp.143~148 (2014)